NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

S. Ettinger, David; E. Wood, Douglas; L. Aisner, Dara; Akerley, Wallace; R. Bauman, Jessica; Bharat, Ankit; S. Bruno, Débora; Y. Chang, Joe; R. Chirieac, Lucian; M. DeCamp, Malcolm; J. Dilling, Thomas; E. Dowell, Jonathan; A. Durm, Gregory; Gettinger, Scott; E. Grotz, Travis; A. Gubens, Matthew; Hegde, Aparna; P. Lackner, Rudy; Lanuti, Michael; Lin, Jules; W. Loo, Billy; M. Lovly, Christine; Maldonado, Fabien; Massarelli, Erminia; Morgensztern, Daniel; Ng, Thomas; A. Otterson, Gregory; Pravin Patel, Sandip; Patil, Tejas; M. Polanco, Patricio; J. Riely, Gregory; W. Riess, Jonathan; E. Schild, Steven; A. Shapiro, Theresa; P. Singh, Aditi; Stevenson, James; L. Tam, Alda; Tanvetyanon, Tawee; Yanagawa, Jane; C. Yang, Stephen; Yau, Edwin; M. Gregory, Kristina; Hughes, Miranda

doi:10.6004/jnccn.2023.0020

Public

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

Published in Journal of the National Comprehensive Cancer Network • Apr 1, 2023

Authors:

David S. Ettinger

Douglas E. Wood

Dara L. Aisner

Abstract

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.

Subject

Medicine

Lung cancer

Oncology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!